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Prevalence of dyspepsia in patients with
cholecystolithiasis: a systematic review and
meta-analysis
Carmen S.S. Latensteina,*, Judith J. de Jongb,*, Jedda J. Eppinkb, Marten A. Lantingaa,
Cornelis J.H.M. van Laarhovena, Philip R. de Reuvera and Joost P.H. Drenthb
Cholecystolithiasis and functional gastrointestinal disorders are both highly prevalent in the industrialized world and may exist
concomitantly. The presence of both conditions impedes identification of the source of symptoms, leading to a risk of ineffective
cholecystectomies with lack of symptom resolution. We carried out a systematic review and meta-analysis to determine the
prevalence of dyspepsia in patients with uncomplicated cholecystolithiasis. The electronic databases Medline, Embase, and Web
of Science were searched for articles reporting the prevalence of dyspepsia in adults (≥18 years) with uncomplicated
cholecystolithiasis. Pooled prevalence and 95% confidence interval were calculated. I2 statistics were used to determine
heterogeneity and the Methodological Evaluation of Observational Research criteria were applied for quality assessment. The
study was reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Of the
1696 studies evaluated, 13 reported the prevalence of dyspepsia in a total of 1227 cholecystolithiasis patients seeking medical
care. The pooled prevalence of dyspepsia in patients with cholecystolithiasis was 65.7% (95% confidence interval: 51–79%).
However, heterogeneity was large across studies. Overall, three studies used validated diagnostic criteria. Variation in diagnostic
measures significantly influenced the prevalence of dyspepsia. In conclusion, symptoms similar to those of functional
gastrointestinal disorders are common in patients with cholecystolithiasis, obscuring the source of abdominal complaints. Tools
to select patients who will benefit from cholecystectomy are paramount to prevent ineffective surgery. Eur J Gastroenterol
Hepatol 31:928–934
Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc.
Introduction
Gallstone disease is a significant burden in the industrialized
world, in particular among middle-aged women, as point esti-
mates indicate a prevalence of 5–22% [1,2]. Cholecystectomy is
now the most common elective abdominal surgery performed
in the USA, with over 750000 operations being performed
annually [3], although an element of overuse undoubtedly
exists. Similarly, the global prevalence of functional gastro-
intestinal disorders (FGID), particularly functional dyspepsia, is
high (20% [4]). Again, in particular, middle-aged women are at
risk of developing functional dyspepsia.
FGID encompasses a group of multifactorial disorders.
Disturbances of the bidirectional brain–gut interaction are
recognized in the pathophysiology of FGID, as well as
visceral hypersensitivity and impaired gastrointestinal
motility [5]. Symptoms roughly correlate with the level of
the gastrointestinal tract that is affected. FGID that
involves the upper or the mid gastrointestinal tract (i.e.
functional dyspepsia) is associated with pain or discomfort
located in the upper abdomen.
Although asymptomatic in the majority of patients,
symptomatic cholecystolithiasis may typically present as
biliary colic [6]. Patients may experience abdominal pain in
the upper right quadrant, frequently radiating to the back,
lasting over 30min, and often accompanied by nausea
or vomiting. However, in many cases, a broad range of
atypical symptoms, such as postprandial pain and bloating,
accompany biliary colic or even dominate presenting symp-
toms [7].
Several studies show that ~40% of patients do not gain
relief from abdominal pain despite cholecystectomy [8–10],
suggesting that postoperative symptoms must be attributed
to a different source. Functional dyspepsia may be over-
looked in patients reporting abdominal symptoms with
cholecystolithiasis and could explain a lack of symptom
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resolution. Currently, it is unclear to what extent FGID plays
a role in these patients.
In view of the varying prevalence of FGID in patients
with cholecystolithiasis and potential impact on the choice
of treatment, there is a need for unambiguous data. We
carried out a systematic review and meta-analysis of
literature to determine the prevalence of dyspepsia in a
healthcare-seeking population with symptomatic, uncom-
plicated cholecystolithiasis. General practitioners, gastro-
enterologists, and surgeons could use these results in future
decision-making.
Methods
This study was reported according to the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA)
statement [11]. Details of the study protocol were registered on
PROSPERO [12]. For this study, IRB approval and informed
consent were not needed.
Search strategy and study selection
A systematic search of the literature was performed in
November 2017 using electronic databases Medline
(1946–November 2017), Embase (1974–November 2017),
and Web of Science (1945–November 2017).
Articles eligible for inclusion had study populations that
included adults of at least 18 years with cholecystolithiasis,
who consulted healthcare services, and in whom the pre-
valence of dyspepsia was assessed. In the case of a surgical
clinic-based setting, only preoperative assessments were
considered for inclusion. Cholecystolithiasis was defined as
the presence of one or more stones in the gallbladder.
Uncomplicated cholecystolithiasis was defined as gall-
stones in the gallbladder, in the absence of stones in bile
ducts, cholecystitis, or cholangitis. The combination of
gallstones and any abdominal symptom was indicated as
symptomatic cholecystolithiasis.
Only studies published after the introduction of laparo-
scopic cholecystectomy in 1985 were included, to represent
current clinical practice. We limited our search to prospective
and cross-sectional studies. Abstracts without published full
texts were included if all data for primary and secondary
endpoints were available. Studies solely studying gallbladder
dyskinesia and biliary dyspepsia were excluded. In addition,
studies with complicated gallstone disease patients were
excluded in case no distinction was made between compli-
cated and uncomplicated disease. Complicated gallstone
disease was defined as the presence of acute cholecystitis,
choledocholithiasis, cholangitis, and biliary pancreatitis. All
eligibility criteria are shown in Supplementary Table S1
(Supplemental digital content 1, http://links.lww.com/EJGH/
A418 in the supplementary files).
To build a search, the following terms were used for
FGID: abdominal pain, functional gastrointestinal dis-
orders, FGID, dyspepsia, and indigestion. These terms
were combined with the set operator ‘OR’. The terms for
FGID were then combined using the set operator ‘AND’
with studies identified with the terms gallstone, biliary
calculi, cholecystolithiasis, cholelithiasis, and gallstones.
Details of the search are shown in the Supplementary
Table S2 (Supplemental digital content 2, http://links.lww.
com/EJGH/A419). In addition, for every keyword
[Medical Subject Headings (MeSH) for Medline and
Emtree for Embase], free text words were searched. The
Cochrane Library was checked with identical keywords.
Cross-references were hand-searched. Two reviewers (J.E.
and C.L.) independently screened titles and abstracts. A
third reviewer (J.J.) resolved differences in article selection
and verified selected articles by means of discussion.
Data extraction
A predefined data extraction form was used. Data were
extracted independently by two reviewers (J.E. and C.L.),
and discrepancies were resolved by the third reviewer (J.J).
The following study characteristics were extracted: first
author, year of publication, country, study design, patient
inclusion and exclusion criteria, type of gastrointestinal
symptoms studied, questionnaire or criteria to define the
functional symptoms, and sample size. The following
additional data were collected for each study: mean age of
patients, sex, and prevalence of dyspepsia. Authors were
contacted in case of missing data. Discrepancies in data
extraction were discussed until a consensus was reached.
Quality assessment
The methodological quality of the studies included was
assessed independently by two reviewers (J.E. and C.L.)
using the Methodological Evaluation of Observational
Research (MORE) [13] and discrepancies were resolved by
the third reviewer (J.J.). This quality assessment tool tests
components of the internal and external validity and
reporting of descriptives of the studies and creates a
validity quality report for each study.
Data synthesis
The proportion of patients with dyspepsia was defined as
the number of patients with a diagnosis of dyspepsia
before treatment for cholecystolithiasis divided by the total
number of patients with uncomplicated cholecystolithiasis.
The term ‘dyspepsia’ was pragmatically used in this review
as a description of upper gastrointestinal complaints,
notwithstanding that the Rome criteria require measures
to exclude organic disorders for functional dyspepsia [14].
The proportions of dyspepsia were combined to calculate
the pooled prevalence of dyspepsia. Methods of measure-
ment were divided into three categories: validated
questionnaires, single symptom, broad definition, and
undefined dyspepsia. The broad definition was defined
according to the 1988 Working Party report, which
defined dyspepsia as upper abdominal or retrosternal pain,
discomfort, heartburn, nausea, vomiting, or other symp-
toms considered to be referable to the proximal alimentary
tract [15].
Statistical analysis
A random-effects model was used for the pooled estimates
and 95% confidence intervals (CIs) as this would yield the
most conservative estimate. The random-effects model was
constructed using MedCalc statistical software version
18.2.1 (MedCalc Software bvba, Ostend, Belgium; 2018).
Continuous data are reported as mean with SD. We used I2
statistics to determine heterogeneity for pooled estimates.
Dyspepsia in cholecystolithiasis Latenstein et al. www.eurojgh.com 929
If appropriate, publication bias will be assessed using a




The search strategy identified 1696 articles. After excluding
duplicates and selection on the basis of title and abstract, 63
articles were screened on full text, of which finally 13 were
included in this review (Fig. 1). Screening references and
contacting study authors did not yield additional studies.
Characteristics
Study characteristics are summarized in Table 1. A total of
1227 patients from 13 studies were included. The majority of
studies were prospective, but in two a cross-sectional design,
was used [16,17]. Three studies used a validated questionnaire
[18–20]. Four studies used a ‘broad definition [21–24], all to
define dyspepsia. In two studies, a single symptom out of a list
Fig. 1. Study identification and selection flow chart. Flow chart of study selection using three databases and cross-referencing. FD, functional dyspepsia; IBS,
irritable bowel syndrome.




Age (range or mean ±SD)
(years) Male (%)
Patients with gallstones and
gastrointestinal symptoms (%)
Lorusso et al. [19] Single-center prospective GSRSc 124 44.4 ± 12a 19.2 46.7
Mertens et al. [21] Single-center prospective Broad definition 183 46.0 ± 11 25.7 66.7
Ibrarullah et al. [22] Prospective Broad definition 43 36.8 (19–62) 23.3 67.4
Schmidt et al. [18] Single-center prospective Simplified Rome IIc 153 48 (17–85) 20.3 87.6
Portincasa et al. [16] Cross-sectional Single symptom 20 44 (21–67) 35.0 60.0
Borly et al. [23] Single-center prospective Broad definition 80 44 (20–70) 11.2 86.0
Berhane et al. [17] Single-center cross-sectional Single symptom 166 47 (19–79)b 26.0 98.0
Berger et al. [20] Multicenter prospective Self-administered
symptom
questionnairec
107 45.7 (17–79) 19.6 82.7
Bagaria et al. [25] Single-center prospective Undefined criteria 25 42.1 20.0 40
Karmacharya et al. [26] Single-center prospective Undefined criteria 96 40.3 (20–75) 12.5 33.3
Kumar et al. [27] Single-center Prospective Undefined criteria 100 43.7 20.0 40
Misrani et al. [28] Single-center cross-sectional Undefined criteria 100 44 (20–70) 20.0 50
Abu Farsakh et al. [24] Single-center prospective Broad definition 30 43.8 (22–70) 16.7 66.7
Questionnaire validated by authors through previous research.
GSRS, Gastrointestinal Symptom Rating Scale.
Broad definition, a group of gastrointestinal symptoms selected by the authors, which together form the definition dyspepsia; Single-symptom definition, one gastrointestinal
suffices to diagnose dyspepsia; Undefined, symptoms are classified as ‘dyspepsia’, but no criteria for the diagnosis were presented.
aMean age at the time of follow-up.
bIncluding complicated gallstone disease.
cQuestionnaire validated by authors through previous research. Besides, this applies to the ‘Simplified Rome II’ questionnaire of Schmidt et al. [18] as well.
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of symptoms (‘single-symptom’) was sufficient to diagnose
dyspepsia. Four studies did not define the definition used for
dyspepsia (undefined) [25–28]. The low number of studies and
high heterogeneity did not allow for a funnel plot or
regression-based assessments for publication bias.
Quality Assessment
The quality assessment of the 14 articles was performed
using the MORE quality assessment. Figure 2 presents the
internal and external validity of all studies and reporting of
descriptives (full quality assessment is presented in
Supplementary Table S3, Supplemental digital content 3,
http://links.lww.com/EJGH/A420 and Supplementary Table
S4, Supplemental digital content 4, http://links.lww.com/
EJGH/A421). Regarding to internal validity, all except three
studies had a major flaw, mostly because they did not assess
the severity of disease. In terms of external validity, all
studies had a major flaw because of a hospital-based setting.
As this was an inclusion criterion for our study, the limited
relevance should be kept in mind during interpretation. In
terms of reporting of descriptives, six studies did not report
ethical approval of their study, 11 did not declare conflicts
of interest, and eight did not report funding of the study. It
should be noted that dyspepsia was a secondary outcome in
most studies and was therefore likely to be analyzed less
extensively.
Prevalence of dyspepsia
The prevalence of dyspepsia in patients with symptomatic
uncomplicated cholecystolithiasis ranged from 33 to 98%.
The study that presented the lowest dyspepsia prevalence
was from Nepal and used undefined criteria [26].
The pooled prevalence for dyspepsia across all 13 studies
was 65.7% (95% CI: 51.1–79.0), with heterogeneity between
Fig. 2. Quality assessment. (a) Quality assessment external validity. (b) Quality assessment internal validity. (c) Quality assessment descriptives. Assessment of
internal and external validity and reporting of descriptive of the studies included according to the Methodological Evaluation of Observational Research (MORE)
criteria [31], modified to fit our target studies. Major and minor flaws were pre-specified separately for internal and external validity and reporting of descriptives.
Reporting quality was scored using the option ‘poor reporting’ for all quality criteria.
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studies (I2=96%, P<001), as shown in Fig. 3. Subgroup
analysis of prevalence by method of symptom measurement
showed pooled prevalence’s of 75.4% (95% CI: 46.4–96.3),
72.6% (95% CI: 60.8–83.1), 80.8 (95% CI: 37.5–100), and
41.0 (95% CI: 33.4–48.8) for validated questionnaires, broad
definition, single symptom, and undefined, respectively. The
subgroup prevalences in the broad definition group were not
statistically different from the overall prevalence, while P was
less than 0.01 for the validated questionnaires, single symptom,
and undefined group. The pooled prevalence of the total and
subgroup analyses is shown in Table 2.
Discussion
Sixty percent of patients with uncomplicated cholecysto-
lithiasis have gastrointestinal symptoms that share features
with functional dyspepsia, which is higher compared with
the general population [4,29]. We found use of a broad
variety of diagnostic tools across studies to diagnose dys-
pepsia, only three of which were validated.
To put our data into perspective, in the UK, over 50 000
cholecystectomies are performed yearly, mostly for symp-
tomatic cholecystolithiasis. According to our data, around
33 000 of these patients will have both cholecystolithiasis
and dyspepsia [30]. Assumedly, many patients are sub-
jected to cholecystectomy because of dyspeptic symptoms
rather than symptomatic gallstones, subsequently causing
long-term persistent abdominal complaints. Three large
studies showed similar proportions of persistent symp-
toms, viz. 37 [31], 40.4 [19], and 59.5% [32]. Previous
literature suggests that if the preoperative assessment is
standardized and other possible causes of abdominal
symptoms are ruled out, the postoperative symptomatic
outcome is significantly improved [33,34]. These symp-
toms are a significant burden on patients and healthcare as
56% of patients will need additional healthcare, against
median costs of $555 per year per patient. Sick leave and
production loss of employed patients add an additional
$361 per year per patient for work-related costs [35].
A lower prevalence of dyspeptic symptoms is seen in
population-based studies with ‘healthy’, unselected patients
[36,37]. Previously, the variation between hospital-based and
population-based prevalences of dyspeptic symptoms was
confirmed and no causal relationship was found between
dyspeptic symptoms and gallstones [38,39]. Only biliary
colic, radiating pain, and use of analgesics were related to
gallstones, supporting our hypothesis that dyspeptic symp-
toms may not be mainly caused by gallstones. Based on these
results, cholecystectomy for dyspeptic symptoms alone,
which has been common practice in the past, is unjustified
and emphasizes the need for stringent indications for
cholecystectomy.
The majority of the studies included were European or
South-Asian. Intercontinental differences in the general pre-
valence of dyspepsia and cholecystolithiasis prevent extra-
polation of our results to other continents [4]. However, as
cholecystolithiasis –of the cholesterol gallstone type – and
FGID are predominantly western diseases, this review was in
advance expected to mainly impact western countries [4,40].
Geographical differences did not cause heterogeneity
between studies.
Fig. 3. Forrest plot (random effects). Forrest plot of meta-analysis on the prevalence of dyspepsia in patients with symptomatic uncomplicated cholecysto-
lithiasis. Squares indicate the prevalence of separate studies; the horizontal line indicates 95% confidence interval (CI); and the diamond indicates the summary
risk estimate with its 95% CI.








confidence interval)] I2 [% (P)]
Pooled prevalence





3 384 75.4 (46.4–96.3) 97 (<0.01)
Broad definition 4 336 72.6 (60.8–83.1) 77 (<0.01)
Single-symptom
definition
2 186 80.8 (37.5–100) 93 (<0.01)
Undefined
dyspepsia
4 321 41.0 (33.4–48.8) 47 (0.13)
Pooled prevalence generated through a random-effects model. Heterogeneity
between studies is represented by I2.
Broad definition, a group of gastrointestinal symptoms selected by the authors,
which together form the definition of dyspepsia; Single-symptom definition, one
gastrointestinal suffices to diagnose dyspepsia; Undefined, symptoms are classi-
fied as ‘dyspepsia’, but no criteria for the diagnosis were presented.
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We included studies providing the prevalence of gas-
trointestinal symptoms were labeled ‘dyspepsia’, to
increase homogeneity. First, authors’ interpretation of
gastrointestinal symptoms being dyspepsia was used to
define our primary outcome. As validated questionnaires
or additional investigations were rarely used, our pre-
sented prevalences are an estimation. Second, the number
of eligible articles was affected. As sample sizes were low
and a variety of diagnostic tools were used, we found
considerable statistical heterogeneity between studies and
wide CIs. The risk of small-study effects should be kept in
mind during interpretation of the results as the actual
prevalence may be overestimated. Still, data generated in
this study provide an important directional vision on
appropriate management of abdominal pain and further
research into this topic should be carried out.
The absence of desired variables is a drawback often
encountered in meta-analyses. In our case, insufficient
information was available on indications for cholecys-
tectomy, laboratory values, and consistent information on
persistence of symptoms. In addition, the general quality of
the studies was limited, mainly because of poor reporting,
low sample sizes, and lack of use of validated instruments.
Extracted prevalences were most often secondary outcomes
of the studies included, for which consequently studies were
not powered. Strengthening our study is the use of the
PRISMA statement throughout this review to ensure a robust
methodology and sufficient quality [11,41]. The MORE
criteria were used to assess the reporting quality of the arti-
cles included [13]. Furthermore, cross-referencing was per-
formed and authors of incomplete data or missing full-texts
were contacted for optimal yield of our search. The result of
our search provides an important overview of the current
literature and highlights the lacunas yet to be filled.
Whereas symptomatic cholecystolithiasis is an indication
for cholecystectomy, the asymptomatic presence of gallstones
is not as only 3–5% progress to complicated cholecysto-
lithiasis [42]. To attribute abdominal symptoms to FGID, in
the presence of gallstones, diagnostic criteria are required.
Dyspepsia is a multifactorial disorder that remains difficult to
define. Important progress in the Rome criteria was made
with the newly presented clusters ‘postprandial distress syn-
drome’ and ‘Epigastric Pain Syndrome’ [43]. In addition, the
current pathophysiologically driven definition of dyspepsia
contributes to the distinction between disorders, such as
dyspepsia and symptomatic cholecystolithiasis [14]. As soon
as diagnostic criteria for FGID in patients with gallstones are
sufficiently clarified, algorithms may be promising future
clinical tools to aid decision-making. Especially when digi-
talized and individually adjustable, as with many virtual
assessors, such contemporary measures have been shown to
effectively select appropriate clinical pathways [44].
Cholecystolithiasis and FGIDs are both associated with
female sex and lifestyle factors. Fatty foods are a well-known
trigger of symptoms in functional dyspepsia [45] as well as of
biliary colic [6]. Targeting the shared lifestyle factor or
initiating other treatments for dyspepsia therefore seems
appropriate in a comorbid population. An initial con-
servative approach may provide exciting opportunities for
future reduction of ineffective cholecystectomies. This not-
withstanding, satisfactory treatment of FGID is a challenge.
Often, patients and clinicians conveniently choose to focus
treatment on radiologically confirmed abnormalities rather
than adopt the complicated path of treating FGID.
Currently, several studies are being carried out by our
group in the field of appropriate cholecystectomies and per-
sistent symptoms. One of these studies is a Dutch nationwide
randomized-controlled trial in which persistent symptoms
and practice variation are compared between the usual and a
restrictive strategy in patients with symptomatic cholecysto-
lithiasis [34]. In a multicenter observational study (Dutch
Trial Register 2018: NTR7307, http://www.trialregister.nl/
trialreg/admin/rctview.asp?TC=7307), FGID according to
the Rome IV criteria are measured in gallstone patients
before and after surgery to identify FGID as a possible cause
of persistent symptoms.
Conclusion
A majority of patients with cholecystolithiasis have symp-
toms similar to functional dyspepsia. Physicians who
encounter patients with gallstones and nonspecific abdominal
symptoms should be aware of this phenomenon. Measures
are needed to select patients who will benefit from chole-
cystectomy to prevent inappropriate surgery.
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